Schedule 13D ownership disclosure
NovaBay Pharmaceuticals Inc
Common Stock, $0.01 par value · CUSIP: 66987P409
Event date: 2025-08-19
- Filing-level shares
- 1,200,048.00
- Percent of class
- 19.99%
- David E. LazarReported CIK 0001932843
Shares: 1,200,048.00 · Class: 19.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-25-006736
- Form type
- SCHEDULE 13D
- Filer
- Lazar David E.
- CIK
- CIK 1932843
- Filed
- Aug 26, 2025
- Reporting period
- Aug 19, 2025
- Description
- Schedule 13D beneficial ownership